InvestorsHub Logo
Followers 43
Posts 10679
Boards Moderated 0
Alias Born 07/15/2007

Re: None

Thursday, 05/21/2009 10:43:37 AM

Thursday, May 21, 2009 10:43:37 AM

Post# of 146301
The competition is gaining!

Vical Advances H1N1 Pandemic Influenza Vaccine - Quick Facts

Vical Advances H1N1 Pandemic Influenza Vaccine - Quick Facts

Thu May 21 06:35:00 2009
EDT
(RTTNews) - Vical Inc. (VICL) said it has completed development of a prototype H1 vaccine, produced
an initial supply of research-grade material, and initiated immunogenicity testing in animals.

Assuming a successful outcome of the testing and a commitment for program-specific external funding,
the company is ready to advance directly to large-scale cGMP manufacturing of vaccine for human clinical

trials to be conducted by the U.S. Navy.


VICL,

BREAKING_NEWS, US, CORPORATE_NEWS,------------------------------------------------------------------------------------------------

HURRY!

Echo20
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News